FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Dr Lalchandani Labs IPO and Indo US BioTech IPO.
Dr Lalchandani Labs IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Indo US BioTech IPO is a SME Fixed Price Issue proposed to list at BSE SME.
Dr Lalchandani Labs IPO | Indo US BioTech IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | BSE SME | BSE SME |
Lead Managers | Navigant Corporate Advisors Ltd | Swastika Investmart Ltd |
Registrar | Cameo Corporate Services Limited | Bigshare Services Pvt Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dr Lalchandani Labs IPO is up to ₹4.20 Cr whereas the issue size of the Indo US BioTech IPO is up to ₹7.29 Cr. The final issue price of Dr Lalchandani Labs IPO is ₹30.00 per share and of Indo US BioTech IPO is ₹51.00 per share.
Dr Lalchandani Labs IPO | Indo US BioTech IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹30.00 per share | ₹51.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 4000 shares | 2000 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 14,00,000 shares | 14,30,000 shares |
Issue Size Total (Amount) | up to ₹4.20 Cr | up to ₹7.29 Cr |
Dr Lalchandani Labs IPO opens on Apr 25, 2018, while Indo US BioTech IPO opens on Apr 30, 2018. The closing date of Dr Lalchandani Labs IPO and Indo US BioTech IPO is Apr 27, 2018, and May 03, 2018, respectively.
Dr Lalchandani Labs IPO | Indo US BioTech IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Apr 25, 2018 | Apr 30, 2018 |
Issue Close | Apr 27, 2018 | May 03, 2018 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Dr Lalchandani Labs IPO P/E ratio is , as compared to Indo US BioTech IPO P/E ratio of .
Dr Lalchandani Labs IPO | Indo US BioTech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Dr Lalchandani Labs IPO retail investors (RII) are offered 6,28,000 shares while in Indo US BioTech IPO retail investors are offered 6,28,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Dr Lalchandani Labs IPO and 0 shares in Indo US BioTech IPO.
Dr Lalchandani Labs IPO | Indo US BioTech IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 72,000 shares | 74,000 shares |
QIB | 0 shares | 0 shares |
NII | 6,28,000 shares | 6,78,000 shares |
RII | 6,28,000 shares | 6,78,000 shares |
Employee | ||
Others | ||
Total | 13,28,000 shares | 14,30,000 shares |
Dr Lalchandani Labs IPO subscribed 4.96x in total, whereas Indo US BioTech IPO subscribed 19.74x.
Dr Lalchandani Labs IPO | Indo US BioTech IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 3.35x | 19.52x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 6.48x | 19.87x |
Employee (times) | ||
Other (times) | ||
Total (times) | 4.96x | 19.74x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|